Skip to content

Clinical trials

Phase 3 Carcinoma trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Phase: Phase 3 Country / region: Austria Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20102
20121
20161
20182
20193
20211
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting3
Recruiting3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC4
Exelixis2
Abbott1
Ariad Pharmaceuticals1
AstraZeneca1
Australasian Gastro-Intestinal Trials Group1
Bayer1
Daiichi Sankyo1
Novartis Pharmaceuticals1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma15
Carcinoma, Non-Small-Cell Lung5
Carcinoma, Hepatocellular4
Lung Neoplasms4
Adenocarcinoma3
Neoplasms3
Carcinoma, Renal Cell2
Carcinoma, Large Cell1
Carcinoma, Squamous Cell1
Digestive System Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.